Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116014) titled 'Clinical efficacy and mechanism study of perfluorohexyl octane combined with cyclosporine in the treatment of chronic ocular graft-versus-host disease secondary dry eye' on Jan. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guabgzhou First People's Hospital
Condition:
Chronic ocular graft-versus-host disease secondary to dry eye.
Intervention:
Experimental group (PFH combined with CsA group):PFH combined with CsA
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-04
Target Sample Size: Experimental group (PFH combined with CsA group):25;contro...